Diabetes
Conference Coverage
Self-injury and suicide ‘all too common’ in type 1 diabetes
“With a multipronged approach to awareness, education, and identification, we have the opportunity to intervene on the link between suicide and...
Guidelines
ADA updates on finerenone, SGLT2 inhibitors, and race-based eGFR
ADA has made an interim change to its latest Standards of Medical Care, an update based on trial evidence and consensus about finerenone, SGLT2...
Conference Coverage
Stem cell transplants could be ‘transformational’ in type 1 diabetes
A second patient who received Vertex’s VX-880 has experienced glycemic improvements, while the first one is completely insulin independent.
Conference Coverage
Antidiabetes drug costs keep patients away
Patients with diabetes and high med co-pays had worse fill rates, but even with low copays uptake of effective but expensive antidiabetes drugs...
Conference Coverage
Obesity in adolescence raises risk for adult type 1 diabetes
Risk of type 1 diabetes was doubled compared with adolescents with optimal body mass index in a study of military recruits.
Conference Coverage
Weekly dulaglutide promising in youth with type 2 diabetes
“Considering that dulaglutide and the GLP-1 agonist class of drugs improve A1c [and] beta-cell function ... dulaglutide would provide a promising...
Conference Coverage
Tirzepatide powers ‘unprecedented’ weight loss in SURMOUNT-1
The twincretin tirzepatide produced jaw-dropping levels of weight loss in people with obesity and no diabetes compared with placebo in the...
Conference Coverage
Will tirzepatide slow kidney function decline in type 2 diabetes?
Compared to insulin glargine, tirzepatide was associated with significantly less new-onset macroalbuminuria in patients with T2D at high...
Feature
ADA 2022 preview: Tirzepatide and much more
Full SURMOUNT-1 data, new approaches to type 2 diabetes management, discoveries in type 1 diabetes prevention and treatment, disparities, mental...
Guidelines
ADA prioritizes heart failure in patients with diabetes
Patients with diabetes should have annual screening for biomarkers of early-stage heart failure, and treatment should prioritize an SGLT2...
Conference Coverage
Early metformin minimizes antipsychotic-induced weight gain
The main benefit of metformin is to flatten rather than reverse antipsychotic-induced weight gain.